Page last updated: 2024-10-25

eucalyptol and Diabetic Cardiomyopathies

eucalyptol has been researched along with Diabetic Cardiomyopathies in 1 studies

Diabetic Cardiomyopathies: Diabetes complications in which VENTRICULAR REMODELING in the absence of CORONARY ATHEROSCLEROSIS and hypertension results in cardiac dysfunctions, typically LEFT VENTRICULAR DYSFUNCTION. The changes also result in myocardial hypertrophy, myocardial necrosis and fibrosis, and collagen deposition due to impaired glucose tolerance.

Research Excerpts

ExcerptRelevanceReference
"In vitro, fibrosis was measured in CFs exposed to HG."1.91TRPA1 deficiency attenuates cardiac fibrosis via regulating GRK5/NFAT signaling in diabetic rats. ( Liu, J; Pan, W; Wan, J; Wang, M; Wei, C; Xu, S; Xu, Y; Yin, Z; Zhang, J; Zhao, M; Zheng, Z, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Wang, M1
Zhao, M1
Xu, S1
Zheng, Z1
Zhang, J1
Pan, W1
Yin, Z1
Liu, J1
Wei, C1
Wan, J1
Xu, Y1

Other Studies

1 other study available for eucalyptol and Diabetic Cardiomyopathies

ArticleYear
TRPA1 deficiency attenuates cardiac fibrosis via regulating GRK5/NFAT signaling in diabetic rats.
    Biochemical pharmacology, 2023, Volume: 214

    Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Eucalyptol; Fibrosis; Rats; Rat

2023